Digital Health Age features a bylined article by Julie Pelta, Senior Advisor in the Healthcare and Life Sciences Practice at DataArt, discussing developments in artificial intelligence for prediction and prevention of major diseases.
Sergey Bludov, SVP of Media and Entertainment at DataArt, contributes a bylined article to ITProPortal, exploring the role of blockchain in solving challenges in various areas of the music industry, including rights, licensing and royalties, live music, touring and fan engagement.
In a contributed byline for IDG Connect, Denis Baranov, Principal Consultant at DataArt, identifies seven current global developments and challenges that will determine whether blockchain will move into active production or fail.
Kirill Timofeev, Software Project Manager at DataArt, presents five fundamental layers of a successful blockchain project in it-finanzmagazin, the leading German publication covering technologies in the financial sector.
ITCM Magazine reports on DataArt being shortlisted for the 2017 Travolution Awards as the Best Travel Technology Team of the Year, for the second year in a row.
In a contributed byline for GDPR:REPORT, Mike Jones and Toby Bryans, executives at DataArt’s Finance Practice, discuss the impact of the upcoming EU’s General Data Protection Regulation (GDPR) on organizations that process personal data of EU and EEA citizens.
In a feature article on using games and coding challenges to recruit the best programmers, CIO Dive spoke with Daniel Lurye, VP of HR Communications at DataArt, who shared the consultancy's effective use of its own community-based game, Skillotron, to recruit, educate, and challenge software engineers.
In HuffPost Tech UK, Dmitry Bagrov, Managing Director of DataArt, UK, shares his vision of seamless and integrated ways of interfacing with digital services that will soon leave cell phones as we know them in the past.
EPM Magazine features a bylined article by Alexander Myskiw, Engagement Manager in the Healthcare and Life Sciences Practice at DataArt, on the promise and risks of combining telehealth solutions with nano drug delivery systems.